CAM
SNDX icon

Cormorant Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Cormorant Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,175,000
Closed -$25.4M – 62
2023
Q4 		$25.4M Buy
+1,175,000
New +$18.1M 1.21% 24
2017
Q2 		– Sell
-240,403
Closed -$3.3M – 77
2017
Q1 		$3.3M Hold
240,403
– – 0.48% 48
2016
Q4 		$1.72M Hold
240,403
– – 0.23% 65
2016
Q3 		$3.65M Buy
240,403
+25,984
+12% +$342K 0.4% 59
2016
Q2 		$2.11M Hold
214,419
– – 0.3% 58
2016
Q1 		$2.86M Buy
+214,419
New +$2.7M 0.43% 54

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return